EP 0937046 A2 19990825 - SUBSTITUTED 3-BENZYLPYRAZOLES AND THEIR USE AS HERBICIDES AND FOR LOWERING THE SUGAR CONTENT IN BLOOD
Title (en)
SUBSTITUTED 3-BENZYLPYRAZOLES AND THEIR USE AS HERBICIDES AND FOR LOWERING THE SUGAR CONTENT IN BLOOD
Title (de)
SUBSTITUIERTE 3-BENZYLPYRAZOLE UND IHRE VERWENDUNG ALS HERBIZIDE UND ZUR SENKUNG DES BLUTZUCKERGEHALTES
Title (fr)
3-BENZYLPYRAZOLES SUBSTITUES ET LEUR UTILISATION COMME HERBICIDES ET POUR ABAISSER LA TENEUR EN SUCRE DU SANG
Publication
Application
Priority
- DE 19645313 A 19961104
- EP 9706057 W 19971103
Abstract (en)
[origin: DE19645313A1] The invention relates to substituted 3-benzylpyrazoles of formula (I), their precursors of formulas (IIa), (IIb), (IIc), their byproducts of formula (III) as well as their salts, wherein R<1> stands for H, C1-C4 alkyl, C1-C4 halogen alkyl, C1-C4 alkyl sulfonyl, C1-C4 halogen alkyl sulfonyl; R<2> stands for C1-C4 alkyl, C1-C4 halogen alkyl, C1-C4 alkoxy, C1-C4 halogen alkoxy, C1-C4 alkyl thio, C1-C4 halogen alkyl thio, C1-C4 alkyl sulfinyl, C1-C4 halogen alkyl sulfinyl, C1-C4 alkyl sulfonyl, C1-C4 halogen alkyl sulfonyl; R<3> stands for H, CN, NO2, halogen, C1-C4 alkyl, C1-C4 halogen alkyl; X<1>-X<5> stands for chemical bond, optionally substituted methylene-, ethylene-, ethene-1,2-diyl or oxymethylene or thiamethylene chain linked through the heteroatom to the phenyl ring; R<4>-R<8> stands for H, CN, NO2, halogen -O-Y<1>-R<9>, -O-CO-Y<1>-R<9>, -N(Y<1>-R<9>) (Y<2>-R<10>), -N(Y<1>-R<9>)-SO2-Y<2>-R<10>, -N(SO2-Y<1>-R<9>) (SO2-Y<2>-R<10>), -N(Y<1>-R<9>)-CO-Y<2>-R<10>, -N(Y<1>-R<9>) (O-Y<2>-R<10>), -S-Y<1>-R<9>, -SO-Y<1>-R<9>, -SO2-Y<1>-R<9>, -SO2-O-Y<1>-R<9>, -SO2-N(Y<1>-R<9>) (Y<2>-R<10>), -CO-Y<1>-R<9>, -C(=NOR<11>)-Y<1>-R<9>, -C(=NOR<11>)-O-Y<1>-R<9>, -C(=NOR<11>)-CO-O-Y<1>-R<9>, -CO-O-Y<1>-R<9>, -CO-S-Y<1>-R<9>, -CO-N(Y<1>-R<9>) (Y<2>-R<10>), -CO-N(Y<1>-R<9>) (O-Y<2>-R<10>); R<12> stands C1-C4 alkyl, C1-C4 halogen alkyl. The invention further relates to the use of (I) as herbicide, for the desiccation/defoliation of plants, and of (I), (IIa), (IIb), (IIc) and (III) for lowering the sugar content in blood.
IPC 1-7
IPC 8 full level
A01N 43/56 (2006.01); A61K 31/415 (2006.01); A61K 31/4152 (2006.01); A61K 31/4155 (2006.01); A61K 31/454 (2006.01); A61K 31/5377 (2006.01); A61P 3/10 (2006.01); C07D 231/20 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 403/10 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01)
CPC (source: EP US)
A61P 3/10 (2017.12 - EP); C07D 231/20 (2013.01 - EP US); C07D 401/10 (2013.01 - EP US); C07D 401/12 (2013.01 - EP US); C07D 403/10 (2013.01 - EP US); C07D 403/12 (2013.01 - EP US); C07D 405/12 (2013.01 - EP US)
Citation (search report)
See references of WO 9820000A2
Designated contracting state (EPC)
CH DE FR GB LI
DOCDB simple family (publication)
DE 19645313 A1 19980507; AU 7001798 A 19980529; CA 2270545 A1 19980514; EP 0937046 A2 19990825; JP 2001503421 A 20010313; US 6451734 B1 20020917; WO 9820000 A2 19980514; WO 9820000 A3 19981029
DOCDB simple family (application)
DE 19645313 A 19961104; AU 7001798 A 19971103; CA 2270545 A 19971103; EP 9706057 W 19971103; EP 97948864 A 19971103; JP 52103998 A 19971103; US 29752999 A 19990503